Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta
Open Access
- 31 July 2004
- Vol. 35 (1) , 231-234
- https://doi.org/10.1016/j.bone.2004.03.008
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Rapid Increase in Grip Force After Start of Pamidronate Therapy in Children and Adolescents With Severe Osteogenesis ImperfectaPublished by American Academy of Pediatrics (AAP) ,2003
- Bone Mass, Size, and Density in Children and Adolescents With Osteogenesis Imperfecta: Effect of Intravenous Pamidronate TherapyJournal of Bone and Mineral Research, 2003
- Osteogenesis Imperfecta Types I, III, and IV: Effect of Pamidronate Therapy on Bone and Mineral MetabolismJournal of Clinical Endocrinology & Metabolism, 2003
- Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfectaArchives of Disease in Childhood, 2002
- Osteogenesis imperfecta: profiles of motor development as assessed by a postal questionnaireEuropean Journal of Pediatrics, 2000
- Pamidronate Treatment of Severe Osteogenesis Imperfecta in Children under 3 Years of AgeJournal of Clinical Endocrinology & Metabolism, 2000
- Effect of First Treatment with Aminobisphosphonates Pamidronate and Ibandronate on Circulating Lymphocyte SubpopulationsJournal of Bone and Mineral Research, 2000
- Cyclic Administration of Pamidronate in Children with Severe Osteogenesis ImperfectaNew England Journal of Medicine, 1998
- Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: A 2-year studyBone, 1996
- Physical growth: National Center for Health Statistics percentilesThe American Journal of Clinical Nutrition, 1979